These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 27748716)

  • 1. Pathophysiology of Immediate Reactions to Injectable Gadolinium-based Contrast Agents.
    Carr TF
    Top Magn Reson Imaging; 2016 Dec; 25(6):265-268. PubMed ID: 27748716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing Allergic Reactions to Gadolinium-Based Contrast Agents.
    Heshmatzadeh Behzadi A; Prince MR
    Top Magn Reson Imaging; 2016 Dec; 25(6):275-279. PubMed ID: 27748715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to Manage (Treat) Immediate-type Adverse Reactions to GBCA.
    Thomsen HS
    Top Magn Reson Imaging; 2016 Dec; 25(6):269-274. PubMed ID: 27849654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subsequent MRI of pediatric patients after an adverse reaction to Gadolinium-based contrast agents.
    Hojreh A; Peyrl A; Bundalo A; Szepfalusi Z
    PLoS One; 2020; 15(4):e0230781. PubMed ID: 32243440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypersensitivity reactions to gadolinium-based contrast agents.
    Fok JS; Smith WB
    Curr Opin Allergy Clin Immunol; 2017 Aug; 17(4):241-246. PubMed ID: 28537933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immediate Allergic Reactions to Gadolinium-based Contrast Agents: A Systematic Review and Meta-Analysis.
    Behzadi AH; Zhao Y; Farooq Z; Prince MR
    Radiology; 2018 Feb; 286(2):471-482. PubMed ID: 28846495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breakthrough Hypersensitivity Reactions to Gadolinium-based Contrast Agents and Strategies to Decrease Subsequent Reaction Rates: A Systematic Review and Meta-Analysis.
    Walker DT; Davenport MS; McGrath TA; McInnes MDF; Shankar T; Schieda N
    Radiology; 2020 Aug; 296(2):312-321. PubMed ID: 32427558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immediate and delayed reactions to radiocontrast media: is there an allergic mechanism?
    Brockow K
    Immunol Allergy Clin North Am; 2009 Aug; 29(3):453-68. PubMed ID: 19563991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insight into the dynamic of gadolinium based contrast agent (GBCA) hypersensitivity: Acquisition, persistence and disappearance.
    Boehm I; Hungerbühler M; Heverhagen JT
    Magn Reson Imaging; 2018 Jun; 49():1-3. PubMed ID: 29247752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventive Effect of Changing Contrast Media in Patients With A Prior Mild Immediate Hypersensitivity Reaction to Gadolinium-Based Contrast Agent.
    Ryoo CH; Choi YH; Cheon JE; Yoon SH; Kang HR; Park SJ; Lee W
    Invest Radiol; 2019 Oct; 54(10):633-637. PubMed ID: 31033674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gadolinium-Based Contrast Agents: Associated Adverse Reactions.
    Ramalho M; Ramalho J
    Magn Reson Imaging Clin N Am; 2017 Nov; 25(4):755-764. PubMed ID: 28964465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin testing for IgE-mediated drug allergy.
    Kränke B; Aberer W
    Immunol Allergy Clin North Am; 2009 Aug; 29(3):503-16. PubMed ID: 19563994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction.
    Martin DR
    Top Magn Reson Imaging; 2016 Dec; 25(6):255. PubMed ID: 27849655
    [No Abstract]   [Full Text] [Related]  

  • 14. Late Diagnosis of Anaphylactic Reaction to Gadolinium-Based Contrast Media by Skin Tests 10 Years After Onset.
    Harr T; Jandus P
    J Investig Allergol Clin Immunol; 2018 Jun; 28(3):203-205. PubMed ID: 29939144
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessment of immediate and non-immediate hypersensitivity contrast reactions by skin tests and provocation tests: A review.
    Bansie RD; Karim AF; van Maaren MS; Hermans MA; van Daele P; Gerth van Wijk R; Rombach SM
    Int J Immunopathol Pharmacol; 2021; 35():20587384211015061. PubMed ID: 34053316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of immediate gadolinium contrast media reactions.
    Prince MR; Zhang H; Zou Z; Staron RB; Brill PW
    AJR Am J Roentgenol; 2011 Feb; 196(2):W138-43. PubMed ID: 21257854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with breakthrough reactions to iodinated contrast media have low incidence of positive skin tests.
    Berti A; Della-Torre E; Yacoub M; Tombetti E; Canti V; Sabbadini MG; Colombo G
    Eur Ann Allergy Clin Immunol; 2016 Jul; 48(4):137-44. PubMed ID: 27425169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Allergy to iodinated contrast media].
    Nicolie B
    Allerg Immunol (Paris); 2002 Oct; 34(8):302-4. PubMed ID: 12449670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical validation of the basophil activation test in immediate hypersensitivity reactions to gadolinium-based contrast agents.
    Cabrera CM; Clarcast M; Palacios-Cañas A
    Int Immunopharmacol; 2023 Apr; 117():110000. PubMed ID: 37012878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification of gadolinium-based contrast agents (GBCAs)-adverse reactions.
    Boehm IB
    Magn Reson Imaging; 2022 Jan; 85():1-2. PubMed ID: 34662698
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.